Literature DB >> 32302995

Editorial. Neurosurgical priority setting during a pandemic: COVID-19.

Mark Bernstein.   

Abstract

Entities:  

Year:  2020        PMID: 32302995      PMCID: PMC7164325          DOI: 10.3171/2020.4.JNS201031

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


× No keyword cloud information.
Priority setting (formerly known as resource allocation) refers to the process of fairly allocating resources when there are competing needs/requests. A simple illustrative example is that of the yearly equipment budget in a hospital wherein three major requests are made of the hospital’s administration for neurosurgical equipment but there are only sufficient funds to purchase two of the three items requested. Which two are selected? How is a fair and ethical decision made? The modern ethical framework “the accountability for reasonableness” helps ensure fairness of decisions. The four pillars of this framework are relevance (i.e., the reasons for the decisions), transparency (i.e., ensuring the major stakeholders are privy to the reasons), appeals (i.e., ensuring the stakeholders can appeal the decision), and oversight (i.e., periodic review to make sure the system is working fairly). Research demonstrates that, in general, patients are appreciative that there is such a system in place.[1] Regarding priority setting during pandemics, we have learned some important lessons from epidemics like SARS,[2] and recent erudite and thoughtful reports are already emerging regarding the current COVID-19 pandemic.[3] Allocating inanimate resources such as money or equipment to a group of surgeons or a hospital is challenging enough, but allocating resources that directly impact individual patients’ lives demands the highest scientific and moral considerations. Having to choose one patient over another for care not only is ethically daunting but it is every physician’s worst nightmare. In spite of the risk to ourselves, our nurses, and other patients, our duty to care supersedes all of these considerations. But how do we best decide which patients’ needs supersede safety and resource considerations and warrant surgery during a period when surgical activity in hospitals is effectively shut down? If our hospitals do not become overwhelmed, for patients requiring emergency life- or limb-saving surgery such as those with epidural and subdural hematomas and selected intracerebral hematomas, the decision is relatively easy, and these cases proceed “as usual.” At the other end of the spectrum are patients with symptomatic spinal stenosis or hyposymptomatic meningiomas where decision-making is also simple: these patients can safely wait many months for surgery with interval medical management of their symptoms. But what about nonemergency but urgent scenarios such as a patient with a brain tumor and progressive hemiparesis or a patient with progressive cervical spondylotic myelopathy? Kantian or deontological ethical theory simplistically advises us to do “the right thing” for each patient irrespective of the consequences, and utilitarianism or consequentialist ethical theory dictates that we do what provides the best results for the largest number of people. The latter theory generally prevails in difficult large-scale health crises like the current COVID-19 pandemic mainly because the needs of the one must be second to the needs of the many in catastrophic situations. In the current pandemic, what exactly are the competing needs? It is not competition for operating room time, as all hospitals presently have plenty of empty operating rooms. It might be competition for beds, as surgical beds may fill up with medical, and specifically COVID-19, patients. However, the main competing interest is the potential deviation from the most desirable situation: to have no surgery going in order to conserve precious resources like masks, gowns, and ventilators and also minimize the safety risk to anesthetists, nurses, and surgeons. In deciding which surgeries should go forward, there are two confounding variables. The first is the biology of disease. All neurosurgeons have seen some malignant gliomas or sizable metastatic tumors progress more slowly than they initially might have thought. In other words, in any given case we do not know precisely how rapidly the disease will progress. The second is our lack of knowledge as to when the COVID-19 curtain will lift, and it will be “business as usual.” If we knew things would be back to normal by a certain date, we could all plan more effectively and make more informed decisions. In fact, we do not know this, and it will likely be several months before things are back to any semblance of normal. So for now, every surgeon who encounters an urgent case must ask him- or herself: “Is this patient likely to be able to safely wait for things to return to normal without incurring further neurological deficit and/or progression of disease to a point where it is less amenable to treatment?” If the answer is yes, the surgeon is morally bound to not clutter up a terribly stressed system with the surgery. If the answer is no, then the surgeon is morally bound to advocate strongly for the patient and navigate the system to get the surgery done in a timely manner. In the event of multiple urgent patients with multiple prognoses being in the queue at the same time, it has been recommended that prioritization decisions should be random, as in a lottery, as opposed to “first come, first served.”[3] In most if not all hospitals, surgeons will not have any dedicated operating room time during the pandemic like they previously had but will submit a case they feel needs to be done to a small committee who will decide whether the case should be done urgently or not. With respect to the accountability-for-reasonableness framework in this setting, the surgeon must clearly articulate the reasons he or she feels the patient needs an urgent operation; the decision-making must be transparent to all stakeholders, including, in an ideal world, the patient; the surgeon must feel comfortable to appeal the decision should he or she not agree with it, and there must be oversight of the process periodically during the affected epoch to ensure its efficacy and fairness. This frightening pandemic highlights the fragility of our planet, but, amidst the chaos and fear, we must all stick to the basic principles of fairness in decision-making regarding, for example, which patients should be operated on in a time when resources are scarce and risk to the entire system is increased by having patients undergo surgery.

Disclosures

The author reports no conflict of interest.
  3 in total

1.  Fair Allocation of Scarce Medical Resources in the Time of Covid-19.

Authors:  Ezekiel J Emanuel; Govind Persad; Ross Upshur; Beatriz Thome; Michael Parker; Aaron Glickman; Cathy Zhang; Connor Boyle; Maxwell Smith; James P Phillips
Journal:  N Engl J Med       Date:  2020-03-23       Impact factor: 91.245

2.  Patients' views on priority setting in neurosurgery: A qualitative study.

Authors:  Caroline Gunaratnam; Mark Bernstein
Journal:  Br J Neurosurg       Date:  2015-08-24       Impact factor: 1.596

3.  SARS and hospital priority setting: a qualitative case study and evaluation.

Authors:  Jennifer A H Bell; Sylvia Hyland; Tania DePellegrin; Ross E G Upshur; Mark Bernstein; Douglas K Martin
Journal:  BMC Health Serv Res       Date:  2004-12-19       Impact factor: 2.655

  3 in total
  10 in total

1.  Safety of Endoscopic Transsphenoidal Pituitary Surgery during the COVID-19 Pandemic and Comparison to the Pre-Pandemic Era.

Authors:  Meriem Amarouche; Samin Rashid; John Eraifej; Anouk Borg; Jane Halliday; Orlando J Warner; Simon A Cudlip
Journal:  J Neurol Surg B Skull Base       Date:  2021-05-27

2.  Impact of the Coronavirus Disease Pandemic and Related Vaccination in an Orthopedic Clinic in the United Arab Emirates: An Observational Study.

Authors:  Seung-Kook Kim; Seo-Jung Park; Dae-Won Cho; Hong-Suk Kwak; Hee-Yon Jin; Su-Hyun Eum; Eun-Jung Heo; Gi-Eun Kim; Ha-Young Ji; Seung-Jun Park
Journal:  Front Surg       Date:  2022-05-31

3.  An Exit Strategy for Resuming Nonemergency Neurosurgery after Severe Acute Respiratory Syndrome Coronavirus 2: A United Kingdom Perspective.

Authors:  Ciaran S Hill; William R Muirhead; Vejay N Vakharia; Hani J Marcus; David Choi
Journal:  World Neurosurg       Date:  2020-06-04       Impact factor: 2.104

Review 4.  Pituitary society guidance: pituitary disease management and patient care recommendations during the COVID-19 pandemic-an international perspective.

Authors:  Maria Fleseriu; Michael Buchfelder; Justin S Cetas; Pouneh K Fazeli; Susana M Mallea-Gil; Mark Gurnell; Ann McCormack; Maria M Pineyro; Luis V Syro; Nicholas A Tritos; Hani J Marcus
Journal:  Pituitary       Date:  2020-08       Impact factor: 4.107

5.  Neurosurgery Residents' Perspective on COVID-19: Knowledge, Readiness, and Impact of this Pandemic.

Authors:  Ahmad K Alhaj; Tariq Al-Saadi; Fadil Mohammad; Said Alabri
Journal:  World Neurosurg       Date:  2020-05-16       Impact factor: 2.104

6.  Impact of the Coronavirus Disease 2019 Pandemic on Working and Training Conditions of Neurosurgery Residents in Latin America and Spain.

Authors:  María F De la Cerda-Vargas; Martin N Stienen; José A Soriano-Sánchez; Álvaro Campero; Luis A B Borba; Bárbara Nettel-Rueda; Carlos Castillo-Rangel; Luis Ley-Urzaiz; Luis H Ramírez-Silva; B A Sandoval-Bonilla
Journal:  World Neurosurg       Date:  2021-03-06       Impact factor: 2.104

7.  Epilepsy surgery in COVID times-a unique conundrum.

Authors:  Mohit Agrawal; Manjari Tripathi; Raghu Samala; Ramesh Doddamani; Bhargavi Ramanujan; P Sarat Chandra
Journal:  Childs Nerv Syst       Date:  2021-04-10       Impact factor: 1.475

8.  Tackling brain metastases from lung cancer during the COVID-19 pandemic.

Authors:  Naveen Mummudi; Anil Tibdewal; Tejpal Gupta; Vijay Patil; Kumar Prabhash; Jai Prakash Agarwal
Journal:  Cancer Rep (Hoboken)       Date:  2020-09-03

9.  Does COVID-19 Affect Survival and Functional Outcome in Emergency and Urgent Neurosurgical Procedures? A Single-Center Prospective Experience During the Pandemic.

Authors:  Giorgio Fiore; Luigi Gianmaria Remore; Leonardo Tariciotti; Giorgio Giovanni Carrabba; Luigi Schisano; Mauro Pluderi; Giulio Andrea Bertani; Stefano Borsa; Marco Locatelli
Journal:  World Neurosurg       Date:  2021-06-22       Impact factor: 2.104

10.  Collateral damage caused by COVID-19: Change in volume and spectrum of neurosurgery patients.

Authors:  Nishant Goyal; Tejas Venkataram; Vineet Singh; Jitender Chaturvedi
Journal:  J Clin Neurosci       Date:  2020-08-19       Impact factor: 1.961

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.